Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial.
Monjazeb AM, Daly ME, Luxardi G, Maverakis E, Merleev AA, Marusina AI, Borowsky A, Mirhadi A, Shiao SL, Beckett L, Chen S, Eastham D, Li T, Vick LV, McGee HM, Lara F, Garcia L, Morris LA, Canter RJ, Riess JW, Schalper KA, Murphy WJ, Kelly K.
Monjazeb AM, et al.
Nat Commun. 2023 Sep 2;14(1):5332. doi: 10.1038/s41467-023-40813-w.
Nat Commun. 2023.
PMID: 37658083
Free PMC article.
Clinical Trial.